Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months

NCT01076621 · clinicaltrials.gov ↗

COMPLETED

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Menopause
Postmenopausal Bleeding

Interventions

DRUG: 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)

Sponsor

Novo Nordisk A/S